Skip to main content

Churg-Strauss Allergic Angiitis News

Related terms: Churg-Strauss Syndrome

Rituximab Not Superior to Conventional Strategy for Eosinophilic Granulomatosis With Polyangiitis

FRIDAY, Aug. 1, 2025 – For patients with eosinophilic granulomatosis with polyangiitis (EGPA), rituximab is not superior to the conventional remission induction strategy, according to a study...

FDA Approves Nucala (mepolizumab) for Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)

December 12, 2017 – The U.S. Food and Drug Administration today expanded the approved use of Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis with polyangiitis (EGPA), a...

Ask a question

To post your own question to our community, sign in or create an account.